BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 36995260)

  • 1. The Ala307Thr polymorphism of the follicle-stimulating hormone receptor (FSHR) gene is associated with the dose of recombinant FSH received during IVF/ICSI treatment.
    Dieamant F; Petersen CG; Vagnini LD; Petersen B; Ricci J; Nicoletti A; Zamara C; Oliani AH; Oliveira JBA; Franco JG
    JBRA Assist Reprod; 2023 Mar; 27(1):78-84. PubMed ID: 36995260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of FSHR diplotypes on ovarian response to standard gonadotropin stimulation for IVF/ICSI.
    Lazaros L; Hatzi E; Xita N; Takenaka A; Sofikitis N; Zikopoulos K; Georgiou I
    J Reprod Med; 2013; 58(9-10):395-401. PubMed ID: 24050028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis.
    van Tilborg TC; Oudshoorn SC; Eijkemans MJC; Mochtar MH; van Golde RJT; Hoek A; Kuchenbecker WKH; Fleischer K; de Bruin JP; Groen H; van Wely M; Lambalk CB; Laven JSE; Mol BWJ; Broekmans FJM; Torrance HL;
    Hum Reprod; 2017 Dec; 32(12):2485-2495. PubMed ID: 29121350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of gene polymorphisms and AMH level in prediction of poor ovarian response in Egyptian women undergoing IVF procedure.
    Motawi TMK; Rizk SM; Maurice NW; Maged AM; Raslan AN; Sawaf AH
    J Assist Reprod Genet; 2017 Dec; 34(12):1659-1666. PubMed ID: 28825151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET.
    Tsakos E; Tolikas A; Daniilidis A; Asimakopoulos B
    Arch Gynecol Obstet; 2014 Dec; 290(6):1249-53. PubMed ID: 25001569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Ser680Asn polymorphism in the follicle-stimulating hormone receptor gene is associated with the ovarian response in controlled ovarian hyperstimulation.
    Huang X; Li L; Hong L; Zhou W; Shi H; Zhang H; Zhang Z; Sun X; Du J
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):577-83. PubMed ID: 25132286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 2: The predicted hyper responder.
    Oudshoorn SC; van Tilborg TC; Eijkemans MJC; Oosterhuis GJE; Friederich J; van Hooff MHA; van Santbrink EJP; Brinkhuis EA; Smeenk JMJ; Kwee J; de Koning CH; Groen H; Lambalk CB; Mol BWJ; Broekmans FJM; Torrance HL;
    Hum Reprod; 2017 Dec; 32(12):2506-2514. PubMed ID: 29121269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 1: The predicted poor responder.
    van Tilborg TC; Torrance HL; Oudshoorn SC; Eijkemans MJC; Koks CAM; Verhoeve HR; Nap AW; Scheffer GJ; Manger AP; Schoot BC; Sluijmer AV; Verhoeff A; Groen H; Laven JSE; Mol BWJ; Broekmans FJM;
    Hum Reprod; 2017 Dec; 32(12):2496-2505. PubMed ID: 29121326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of follicle-stimulating hormone receptor (FSHR) -29 and Ser680Asn polymorphisms in IVF/ICSI.
    Paschalidou C; Anagnostou E; Mavrogianni D; Raouasnte R; Klimis N; Drakakis P; Loutradis D
    Horm Mol Biol Clin Investig; 2020 Mar; 41(2):. PubMed ID: 32114522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent polymorphisms of FSH receptor do not influence antral follicle responsiveness to follicle-stimulating hormone administration as assessed by the Follicular Output RaTe (FORT).
    Genro VK; Matte U; De Conto E; Cunha-Filho JS; Fanchin R
    J Assist Reprod Genet; 2012 Jul; 29(7):657-63. PubMed ID: 22527896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of FSHR rs6165 and ESR2 rs4986938 polymorphisms in ovarian stimulation of Iranian women who underwent assisted reproduction treatment.
    Kaviani M; Ghaderian SMH; Arefi S; Hashemi M; Afjeh SSA
    Hum Antibodies; 2017; 26(3):121-126. PubMed ID: 29036809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of recombinant versus highly purified follicle-stimulating hormone according to follicle-stimulating hormone receptor genotype.
    Lledó B; Dapena P; Ortiz JA; Morales R; Llacer J; Bernabeu R
    Pharmacogenet Genomics; 2016 Jun; 26(6):288-93. PubMed ID: 26959715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variations altering FSH action affect circulating hormone levels as well as follicle growth in healthy peripubertal girls.
    Busch AS; Hagen CP; Almstrup K; Main KM; Juul A
    Hum Reprod; 2016 Apr; 31(4):897-904. PubMed ID: 26905078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follicle-stimulating hormone receptor gene polymorphisms are not associated with ovarian reserve markers.
    Mohiyiddeen L; Newman WG; McBurney H; Mulugeta B; Roberts SA; Nardo LG
    Fertil Steril; 2012 Mar; 97(3):677-81. PubMed ID: 22265040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of allelic combinations of FSHR gene polymorphisms with ovarian response.
    Desai SS; Achrekar SK; Paranjape SR; Desai SK; Mangoli VS; Mahale SD
    Reprod Biomed Online; 2013 Oct; 27(4):400-6. PubMed ID: 23953588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luteal phase stimulation in double ovarian stimulation cycles is not affected by the follicle-stimulating hormone (FSH) receptor genotype: double ovarian stimulation is beneficial independently of the genotype at position 680 of the follicle-stimulating hormone receptor.
    Hortal M; Lledo B; Ortiz JA; Fuentes A; García-Ajofrín C; Romero R; Cascales A; Bernabeu A; Bernabeu R
    Pharmacogenet Genomics; 2024 Jan; 34(1):1-7. PubMed ID: 37824400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicle-stimulating hormone receptor polymorphism (G-29A) is associated with altered level of receptor expression in Granulosa cells.
    Desai SS; Achrekar SK; Pathak BR; Desai SK; Mangoli VS; Mangoli RV; Mahale SD
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2805-12. PubMed ID: 21752882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the FSH receptor single nucleotide polymorphisms (FSHR 307/680) on the follicular fluid hormone profile and the granulosa cell gene expression in human small antral follicles.
    Borgbo T; Jeppesen JV; Lindgren I; Lundberg Giwercman Y; Hansen LL; Yding Andersen C
    Mol Hum Reprod; 2015 Mar; 21(3):255-61. PubMed ID: 25403644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between FSH receptor polymorphism status and IVF cycle outcome: a retrospective observational study.
    König TE; van der Lee J; Schats R; Lambalk CB
    Reprod Biomed Online; 2019 Aug; 39(2):231-240. PubMed ID: 31279715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.